Other
Quality of Life
0
Pipeline Programs↗
23
Active Trials↗
18
Companies Involved↗
Quality of Life is an early-stage landscape with 0 programs across 18 companies. The most active players are Boehringer Ingelheim, Bayer, Johnson & Johnson.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
118
clinical trials
Completed71 · 60%
Unknown status17 · 14%
Recruiting11 · 9%
Not yet recruiting7 · 6%
Terminated6 · 5%
Enrolling by invitation3 · 3%
Other3 · 3%
Clinical Trials
Trial Activity
118 trials
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Recruiting·—·Phase 2·NCT05765500·110 enrolled
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Active, not recruiting·—·N/A·NCT02839291·148 enrolled
Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
Not yet recruiting·—·Phase 2·NCT05754801·172 enrolled
Benson Relaxation Technique Effectiveness on Pain and Quality of Life Post Reconstructive Mammoplasty
Not yet recruiting·—·N/A·NCT07032883·68 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)